These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 37508292)
1. Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study. Szabó BG; Czél E; Nagy I; Korózs D; Petrik B; Marosi B; Gáspár Z; Rajmon M; Di Giovanni M; Vályi-Nagy I; Sinkó J; Lakatos B; Bobek I Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508292 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study. Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. Bay P; Audureau E; Préau S; Favory R; Guigon A; Heming N; Gault E; Pham T; Chaghouri A; Turpin M; Morand-Joubert L; Jochmans S; Pitsch A; Meireles S; Contou D; Henry A; Joseph A; Chaix ML; Uhel F; Roux D; Descamps D; Emery M; Garcia-Sanchez C; Levy D; Burrel S; Mayaux J; Kimmoun A; Hartard C; Pène F; Rozenberg F; Gaudry S; Brichler S; Guillon A; Handala L; Tamion F; Moisan A; Daix T; Hantz S; Delamaire F; Thibault V; Souweine B; Henquell C; Picard L; Botterel F; Rodriguez C; Dessap AM; Pawlotsky JM; Fourati S; de Prost N; Ann Intensive Care; 2024 Apr; 14(1):65. PubMed ID: 38658426 [TBL] [Abstract][Full Text] [Related]
5. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666 [TBL] [Abstract][Full Text] [Related]
6. Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study. Lakatos B; Szabó BG; Bobek I; Kiss-Dala N; Gáspár Z; Riczu A; Petrik B; Farkas BF; Sebestyén G; Gopcsa L; Bekő G; Sinkó J; Reményi P; Szlávik J; Mathiász D; Vályi-Nagy I Int J Infect Dis; 2022 Dec; 125():233-240. PubMed ID: 36328291 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P; Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848 [TBL] [Abstract][Full Text] [Related]
8. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study. Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058 [TBL] [Abstract][Full Text] [Related]
9. Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study. Gragueb-Chatti I; Lopez A; Hamidi D; Guervilly C; Loundou A; Daviet F; Cassir N; Papazian L; Forel JM; Leone M; Dellamonica J; Hraiech S Ann Intensive Care; 2021 May; 11(1):87. PubMed ID: 34057642 [TBL] [Abstract][Full Text] [Related]
10. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study. Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462 [TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B; Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423 [TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study. Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369 [TBL] [Abstract][Full Text] [Related]
13. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave. Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851 [TBL] [Abstract][Full Text] [Related]
14. Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. Burger BJ; Epps SM; Cardenas VM; Jagana R; Meena NK; Atchley WT Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629609 [TBL] [Abstract][Full Text] [Related]
15. Bloodstream infections in critically ill patients with COVID-19. Giacobbe DR; Battaglini D; Ball L; Brunetti I; Bruzzone B; Codda G; Crea F; De Maria A; Dentone C; Di Biagio A; Icardi G; Magnasco L; Marchese A; Mikulska M; Orsi A; Patroniti N; Robba C; Signori A; Taramasso L; Vena A; Pelosi P; Bassetti M Eur J Clin Invest; 2020 Oct; 50(10):e13319. PubMed ID: 32535894 [TBL] [Abstract][Full Text] [Related]
16. Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study. Bartoszewicz M; Czaban SL; Bartoszewicz K; Kuźmiuk D; Ładny JR Ther Adv Infect Dis; 2023; 10():20499361231207178. PubMed ID: 37869469 [TBL] [Abstract][Full Text] [Related]
17. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic. Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631 [TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M; Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093 [TBL] [Abstract][Full Text] [Related]
19. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M; JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669 [TBL] [Abstract][Full Text] [Related]
20. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]